Neil Wilkie

University of Glasgow — United Kingdom

Medicine · Health Sciences

40h-index5.6kcitations92works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Herpesvirus Infections and Treatments(32), Virus-based gene therapy research(20), Cytomegalovirus and herpesvirus research(12), RNA and protein synthesis mechanisms(7), Viral Infectious Diseases and Gene Expression in Insects(6)

Publications92 total

Kickstarting the Use of AI and Data Across the Biotech Industry
Preprints.org·2024· 1 citedOpen Access
Signaling pathway evaluation of leading ATRi, PARPi and CDK7i cancer compounds targeting the DNA Damage Response using Causal Inference
2024Open Access
The Effect of Stem Cell Proliferation Regulators Demonstrated With
2016
Ubiquitination, E3 ligases and drug discovery Novel technologies for a challenging pathway
2012· 2 cited
βTrCP and cancer – creating novel inhibitors of the SCF E3 ligases
2011
11th Meeting of the Irish Society of Human Genetics, Friday 12th September 2008
Ulster medical journal/˜The œUlster medical journal·2009
The Novel γ Secretase Inhibitor N-[cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) Reduces Amyloid Plaque Deposition without Evidence of Notch-Related Pathology in the Tg2576 Mouse
Journal of Pharmacology and Experimental Therapeutics·2006· 83 cited
Substituting c-Jun N-terminal kinase-3 (JNK3) ATP-binding site amino acid residues with their p38 counterparts affects binding of JNK- and p38-selective inhibitors
Archives of Biochemistry and Biophysics·2005· 11 cited
P4-344 Gleevec and GSK-3 inhibitors have no effect no abeta production in APP-expressing cell lines
Neurobiology of Aging·2004
MAPKs: new targets for neurodegeneration
Expert Opinion on Therapeutic Targets·2003· 112 cited
MAPKs: new targets for neurodegeneration
Expert Opinion on Therapeutic Targets·2003· 6 cited
The management and restoration of damaged blanket bog in the north of Scotland
Botanical Journal of Scotland·2003· 8 cited
The non‐peptidyl fungal metabolite L‐783,281 activates TRK neurotrophin receptors
Journal of Neurochemistry·2001· 48 cited
Growth factors regulate the survival and fate of cells derived from human neurospheres
Nature Biotechnology·2001· 341 cited
The Staurosporine-Like Compound L-753,000 (NB-506) Potentiates the Neurotrophic Effects of Neurotrophin-3 by Acting Selectively at the TrkA Receptor
Molecular Pharmacology·1999· 29 cited
The Staurosporine-Like Compound L-753,000 (NB-506) Potentiates the Neurotrophic Effects of Neurotrophin-3 by Acting Selectively at the TrkA Receptor
Molecular Pharmacology·1999· 2 cited
Identification of amino acids involved in the binding of hMIP-1α to CC-CKR1, a MIP-lα receptor found on neutrophils
Molecular and Cellular Biochemistry·1999· 5 cited
Angiotensin II responses of vascular smooth muscle cells from hypertensive rats: enhancement at the level of p42 and p44 mitogen activated protein kinase
British Journal of Pharmacology·1997· 32 citedOpen Access
Pathways to mitogenesis in vascular smooth muscle cells stimulated with angiotensin II
Figshare·1997· 1 citedOpen Access
Stimulated Mitogen-activated Protein Kinase Is Necessary but Not Sufficient for the Mitogenic Response to Angiotensin II
Journal of Biological Chemistry·1996· 51 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Andrew J. Davison(7), Demetrios�� Spandidos(6), J. Barklie Clements(6), N. D. Stow(5), M. C. Timbury(4), J. H. Subak‐Sharpe(4), Jas C. Lang(4), H. S. Marsden(3), V. G. Preston(3), David Onions(3), Sarah Harper(3), Semantha Ellis(3), Michael R. Boarder(3), Monica Stewart(2), James C. Neil(2), Robert McFarlane(2), Pierre Chartrand(2), Clyde S. Crumpacker(2), Peter Sanders(2), Pascal Chartrand(2)